A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy

Dendritic cells (DCs) are professional antigen-presenting cells with antigen recognition molecules on the surface. Clec9a is selectively expressed on mouse CD8a(+) DCs and CD103(+) DCs subsets, which are functionally similar to human BDCA3(+) DCs. It is reported that Clec9a is responsible for the an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Yan, Zhongyi, Wu, Yahong, Du, Jiangfeng, Li, Guodong, Wang, Shengdian, Cao, Wenpeng, Zhou, Xiuman, Wu, Chunjing, Zhang, Dan, Jing, Xueli, Li, Yifan, Wang, Hongfei, Gao, Yanfeng, Qi, Yuanming
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5130018/
https://ncbi.nlm.nih.gov/pubmed/27250027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9624
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi